Mersana Therapeutics, Inc. (MRSN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.5250 |
| Open | 3.4600 |
| Bid | 3.3800 x 200 |
| Ask | 3.4500 x 400 |
| Day's range | 3.3200 - 3.5250 |
| 52-week range | 0.8010 - 9.6200 |
| Volume | |
| Avg. volume | 2,144,500 |
| Market cap | 416.027M |
| Beta (5Y monthly) | 1.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
Curis (CRIS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
- Insider Monkey
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript February 28, 2024 Mersana Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Mersana Therapeutics Fourth Quarter 2023 Conference Call and Webcast. Currently, all […]
- Simply Wall St.
An Intrinsic Calculation For Mersana Therapeutics, Inc. (NASDAQ:MRSN) Suggests It's 26% Undervalued
Key Insights Mersana Therapeutics' estimated fair value is US$6.60 based on 2 Stage Free Cash Flow to Equity Mersana...
© 2024 Yahoo. All rights reserved.